Clozaril

Quick links to important sections

Clozaril

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clozaril

Property Description
Active ingredient Clozapine
Form Oral tablet, orally disintegrating tablet, oral suspension
Pharmacological class Atypical antipsychotic (SGA), psychotropic medication
General purpose Management of severe mental illness, especially treatment resistance
Origin Synthetic; a tricyclic dibenzodiazepine derivative

What is Clozaril, and What Type of Drug is it?

Clozaril is the trade name for the synthetic medicine containing the active ingredient Clozapine, which is broadly classified as a psychotropic medication and specifically a second-generation antipsychotic (SGA), or atypical antipsychotic. This substance is a tricyclic dibenzodiazepine derivative and is delivered as a single-ingredient product intended for oral administration, utilizing various dosage forms including the standard oral tablet and the orally disintegrating tablet (such as Versacloz). Clozaril’s unique positioning is clinically recognized because it was the first medicine of its class to demonstrate effectiveness in patients who had not responded to standard treatments, establishing its distinction from older antipsychotic compounds.

Why is Clozapine Considered a Foundational Atypical Antipsychotic?

Clozapine is established as a foundational compound due to its complex pharmacodynamic profile, which utilizes broad receptor modulation across both dopamine and serotonin receptor systems, providing a systemic regulatory benefit. This differentiated mechanism is why pharmacological studies consistently support its role as the definitive option for managing treatment-resistant schizophrenia. This means that for individuals with severe, persistent thought disorders, Clozapine provides a critical pharmacological tool to help stabilize perception and behavior. Its efficacy has been shown to extend beyond standard symptom relief, uniquely benefiting individuals who require this distinct mechanism of action within the atypical antipsychotic class.

What side effects are possible with Clozaril?

The officially documented safety profile for Clozaril (clozapine) is characterized by a requirement for routine patient observation due to the risk of serious adverse reactions, as defined by government regulatory agencies. All safety information is based on official prescribing information, such as that provided by the FDA and EMA.

Adverse Reaction Scope

Classification Examples of Officially Documented Adverse Reactions
Very Common (ge1/10) Drowsiness/Sedation, Tachycardia, Hypersalivation, Constipation
Common (ge1/100 to <1/10) Seizures, Weight Gain, Syncope, Tremor, Postural Hypotension

Serious adverse reactions, which are explicitly highlighted in regulatory labeling, include Severe Neutropenia/Agranulocytosis (a reduction in white blood cells), Myocarditis and Cardiomyopathy (heart inflammation/structural change), and severe Gastrointestinal Hypomotility (leading to paralytic ileus).

Reactions are formally grouped by System-Organ Class (SOC), covering Blood and Lymphatic System Disorders, Cardiac Disorders, Nervous System Disorders, and Metabolism and Nutrition Disorders.

Safety-Related Context and Limitations

The label officially documents specific time- and dose-dependent patterns. The highest risk for Agranulocytosis is during the first 18 weeks of treatment, while the risk for Myocarditis is greatest during the first month. The incidence of Seizures is officially classified as being dose-related.

Regulatory documents include specific safety constraints and a warning of increased mortality for older adults with dementia-related psychosis treated with atypical antipsychotics. Continued treatment is contingent upon mandatory Absolute Neutrophil Count (ANC) monitoring.

Overdose and Emergency Response

Overdose and When to Seek Help

The official information regarding Clozaril (clozapine) overdose is derived strictly from regulatory documentation and describes specific manifestations affecting the central nervous system (CNS), cardiovascular system, and respiratory system.

Documented Clinical Manifestations

Overdose is officially documented to present with impaired consciousness, which can range from drowsiness and confusion to coma and areflexia. Significant cardiovascular effects include tachycardia, hypotension, and various cardiac arrhythmias. The potential for seizures and respiratory depression is also noted in official labeling. Other documented signs include hypersalivation, hyperthermia, and pupil changes.


Severe Outcomes and Emergency Actions

Severe or life-threatening outcomes are specifically noted in regulatory documentation, including the risk of circulatory collapse, cardiac failure, and aspiration pneumonia, which have been linked to fatalities. The official guidance mandates that any suspected overdose requires immediate medical attention due to the potential for severe complications.

  • Antidote Status: Regulatory information states that no specific antidote for clozapine is known.
  • Management Focus: Treatment is primarily symptomatic and supportive, requiring close medical supervision, continuous cardiac monitoring (ECG), and maintenance of a patent airway until full clinical recovery.
  • Exposure Note: Life-threatening comatose conditions have been reported in individuals not previously exposed to the drug at relatively low doses.

Therapeutic Uses of Clozaril

What Clozaril Treats: Main Uses and Benefits

Clozaril (Clozapine) is a medication reserved for specific, severe clinical situations, focusing on providing supportive symptomatic relief and assistance in minimizing certain risks in situations where previous treatments have not provided adequate symptomatic relief.

The primary therapeutic areas for this medication involve managing treatment-resistant schizophrenia and reducing the chronic risk of recurrent suicidal behavior in individuals with schizophrenia or schizoaffective disorder. This approach addresses both severe psychotic symptoms, such as hallucinations and delusions, and debilitating negative symptom domains, contributing to easing the overall symptom load where symptoms interfere with daily functioning.

“This particular benefit may assist with reducing the personal and clinical consequences associated with recurrent self-harm behavior in this population.”

A specialized area of use is in the management of hallucinations and delusions in patients with Parkinson's disease, where it is applied in addressing these manifestations in conditions involving increased neurological activity. Clozaril assists with maintaining functional stability when symptoms are more noticeable, particularly in situations with pronounced symptomatic manifestations.

Quick Fact Relief for
Primary Focus Protracted Psychotic Symptoms
Secondary Focus Suicidal Ideation and Attempts

Eligibility and Restrictions for Use

The eligibility to use Clozaril (Clozapine) is strictly defined by regulatory authorities due to the risk of severe blood disorders and other complications. Patients must meet specific health criteria to begin and continue therapy.

Contraindicated Populations

Clozaril must not be used by individuals with a prior history of Clozapine-induced agranulocytosis or severe neutropenia, or those with impaired bone marrow function. Use is also strictly prohibited for patients with uncontrolled epilepsy, severe cardiac disorders (e.g., myocarditis), or severe renal or active liver disease.

Age-Specific Restrictions

Age Group Eligibility Status
Pediatric Patients Safety and effectiveness have not been established; use is not recommended in children and adolescents.
Older Adults Not approved for treating dementia-related psychosis due to increased mortality risk.

Conditional Use and Eligibility Requirements

Eligibility is conditional upon the patient's capacity to meet and maintain an Absolute Neutrophil Count (ANC) above a specific threshold before and during treatment. For pregnant women, use is not recommended unless the benefit clearly outweighs the potential risk. Breastfeeding must be discontinued during therapy, as the medicine is excreted into human milk.

What should I know about interactions with other medicines?

Clozaril (clozapine) interacts with many medications, herbal supplements, and other substances, which can lead to increased side effects or reduced effectiveness. Always inform your healthcare provider of all prescription, over-the-counter, vitamin, and herbal products you are currently taking or plan to start.

Medications that Increase Clozaril Levels (Increased Risk of Side Effects)

Certain medicines slow the breakdown of clozapine in the body, which increases its concentration in the blood, potentially raising the risk of side effects like seizures, sedation, and heart rhythm changes. Examples include:

  • Antidepressants: Fluvoxamine, Fluoxetine, Paroxetine.
  • Antibiotics: Ciprofloxacin, Erythromycin.
  • Other Medications: Caffeine (in large amounts), Cimetidine, Oral contraceptives.

Medications that Decrease Clozaril Levels (Reduced Effectiveness)

Some drugs speed up the metabolism of clozapine, which lowers its blood concentration and may reduce its effectiveness, potentially leading to a worsening of psychiatric symptoms. Examples include:

  • Anticonvulsants: Carbamazepine, Phenytoin.
  • Antibiotic: Rifampin.
  • Herbal Products: St. John’s wort.

Increased Risk of Bone Marrow or CNS Depression

Combining Clozaril with drugs that also have the potential to suppress bone marrow function (e.g., certain cancer medicines, immunosuppressants) is generally avoided due to the heightened risk of severe neutropenia. Additionally, concomitant use of alcohol or medications that depress the central nervous system (e.g., benzodiazepines, narcotics, other sedating agents) can lead to increased sedation, respiratory depression, and profound drowsiness. Smoking status can also affect clozapine levels; quitting smoking may increase blood levels, requiring dose adjustment.

Mechanism of Action

Clozapine acts on the central nervous system through a mathbfpromiscuous pharmacological profile involving multiple G-protein coupled receptors. Its primary actions are antagonism at the mathbfserotonin 5-HT2A receptor and the mathbfdopamine D2 receptor, with a higher affinity for 5-HT2A than D2. Clozapine also demonstrates antagonism at D4 and D1 dopamine receptors, various muscarinic acetylcholine receptors (M1-M5), several adrenergic receptors (alpha1, alpha2), and histamine H1 receptors.

The antagonism of 5-HT2A and D2 receptors modulates dopaminergic and serotonergic neurotransmission in limbic and cortical pathways. Specifically, the strong 5-HT2A antagonism can lead to an increase in dopamine release in certain brain regions. The active metabolite, norclozapine, is a partial agonist at the M1 muscarinic receptor, contributing to subsequent intracellular signaling via Akt-mediated pathways. The net effect is a widespread system-level physiological modulation of multiple monoaminergic and cholinergic pathways across the brain, including downstream cascades involving kinases like ERK1/2.

Dosage and Administration Information

Official Clozaril Administration Instructions

Clozaril (clozapine) is administered via the oral route (by mouth), and its use is subject to mandatory procedures and strict dosing schedules.

Procedural Prerequisite

Treatment initiation requires a baseline Absolute Neutrophil Count (ANC) test. Clozaril should only be started if the ANC is at least 1500/mu L for the general population. Continued use depends on a regular, mandated ANC monitoring schedule throughout therapy and for at least four weeks after discontinuation.

Dosing Schedule and Titration

The starting oral dosage for most adults is 12.5,mg once daily or twice daily. The total daily dose is gradually increased in increments of 25,mg to 50,mg per day, if tolerated. The goal is to reach a target range of 300,mg to 450,mg per day within two weeks, administered in divided doses. The maximum recommended daily dose is 900,mg.

  • Administration Timing: Clozaril can be taken with or without food. Doses are typically divided, with the largest portion often taken at bedtime.
  • Elderly Patients: Treatment for patients 60 years and older must be initiated at a particularly low dose (12.5,mg once daily) with slower, restricted increments of 25,mg per day.

Missed Doses and Re-initiation

If treatment is interrupted for 2 days or more (48 hours), the medicine must be re-initiated at the starting dose of 12.5,mg once or twice daily. This re-titration is necessary to manage cardiovascular risks associated with resuming the medicine.

Recent Clinical Evidence

Efficacy in Treatment-Resistant Schizophrenia

Clozapine is widely recognized and studied as a treatment option for treatment-resistant schizophrenia (TRS), defined as inadequate response to two or more previous antipsychotic medications. Meta-analyses and randomized controlled trials (RCTs) consistently report that clozapine is associated with greater symptom reduction, as measured by the Positive and Negative Syndrome Scale (PANSS), compared to other second-generation antipsychotics in the TRS population.

Additional Treatment Effects

Research has explored the role of clozapine beyond core psychotic symptoms, including in areas of high clinical need:

  • Reduction of Suicidal Behavior: Clozapine is the only antipsychotic medication to receive an indication for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. Studies have documented a significant reduction in suicide attempts and completed suicides among clozapine-treated patients.
  • Aggressive Behavior: Clinical trials, including comparative studies, have shown clozapine to be associated with a greater reduction in aggressive behaviors compared to other antipsychotics in patients with schizophrenia and co-occurring conduct disorder.

Safety Profile and Ongoing Research

The established safety concerns, such as the risk of agranulocytosis (a severe decrease in white blood cells) and myocarditis (inflammation of the heart muscle), necessitate regular monitoring. Recent research efforts have focused on managing these risks and optimizing treatment:

  • Gastrointestinal Hypomotility: Regulatory bodies have issued strengthened warnings regarding the risk of severe constipation and gastrointestinal blockage (ileus) associated with clozapine, emphasizing the importance of active monitoring and management in clinical practice.
  • Cognitive Effects: Preliminary data from studies involving the clozapine metabolite, N-desmethylclozapine, is exploring the compound's potential to influence cognitive function, which is a known area of difficulty for many patients with schizophrenia.

Frequently Asked Questions (FAQ)

Common questions about Clozaril (FAQ)

Q: How often do I need blood tests when taking Clozaril?

A: Regulatory documents indicate that the required Absolute Neutrophil Count (ANC) monitoring schedule is typically weekly for the first six months of treatment. Frequency then often changes to every two weeks for the next six months, and monthly thereafter, as determined by the prescriber for as long as treatment continues.


Q: What is the main difference between Clozaril and other common antipsychotics like Risperdal or Zyprexa?

A: Clozaril is categorized as an atypical antipsychotic, but it has a unique way of working on multiple chemical messengers in the brain. Official documents highlight its distinction because it is specifically indicated for treating schizophrenia that has not responded to other medicines and for reducing the risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder.


Q: Does Clozaril cause long-term weight gain?

A: Yes, regulatory documents indicate that antipsychotic drugs, including Clozaril, have been associated with metabolic changes that may lead to significant weight gain. Due to these changes, which may increase cardiovascular risk, monitoring weight during treatment is generally recommended.


Q: Is it normal to feel really tired when starting Clozaril?

A: Yes. Official product information lists drowsiness and sedation as very common adverse reactions. This means that these effects occur in 10% or more of patients, particularly during the initiation of treatment.


Q: Can you drink coffee or caffeine while on Clozaril?

A: Products containing caffeine, particularly in large amounts, can interfere with how the body processes Clozaril. This can lead to increased levels of the medication in the blood, potentially raising the risk of side effects. Any significant changes in caffeine consumption should be discussed with a healthcare provider, as it may necessitate a dosage adjustment.


Q: What are the main things I should avoid eating or drinking while on Clozaril?

A: Regulatory information advises avoiding or strictly limiting alcohol use, as combining it with Clozaril can dangerously increase sedation, drowsiness, and respiratory depression. It is also advised to moderate products containing caffeine, as large amounts can increase the drug's levels in the blood.


Q: Does smoking affect how well Clozaril works?

A: Yes, smoking status affects the concentration of Clozaril in the blood. Regulatory documents note that quitting smoking can increase the blood level of the drug, which may then require a dosage adjustment to maintain the correct balance and manage potential side effects.


Q: Can Clozaril cause stomach issues or constipation?

A: Constipation is listed in product labeling as a very common side effect. More seriously, Clozaril has been associated with severe gastrointestinal hypomotility (slowed gut movement) which can lead to serious complications. Monitoring and management of bowel movements are emphasized due to these risks.


Q: Can Clozaril cause low blood pressure or dizziness?

A: Yes, official warnings indicate that adverse reactions can include orthostatic hypotension (a drop in blood pressure when standing up), bradycardia (slow heart rate), and syncope (fainting or dizziness). These effects are considered a serious risk, especially during initial titration.


Q: Can Clozaril cause twitching or involuntary movements (tardive dyskinesia)?

A: Official product labeling lists tremor as a common side effect. While the label does not explicitly name tardive dyskinesia, the drug belongs to a class of medications that can be associated with various extrapyramidal motor system disorders.


Q: Do children or adolescents ever take Clozaril?

A: The safety and effectiveness have not been established in pediatric patients. As such, use in those under 18 years of age is not recommended according to official prescribing information.


Q: How do doctors decide if a patient needs Clozaril?

A: Regulatory documents indicate the medicine is typically used for patients diagnosed with schizophrenia that is treatment-resistant (meaning they have not adequately responded to two or more other antipsychotics). It is also indicated for reducing the risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorder.


Q: What should I do if I experience excessive drooling while on Clozaril?

A: Hypersalivation (excessive drooling) is listed in regulatory information as a very common side effect. While this symptom is common, official prescribing information directs patients to report any serious or concerning side effects to a healthcare provider.


Q: Can Clozaril be used for non-schizophrenia-related psychoses?

A: Clozaril is primarily indicated for schizophrenia and to reduce suicidal risk in schizophrenia or schizoaffective disorder. In some regions, official indications include psychotic disorders that occur during the course of Parkinson’s disease.


Q: What are the withdrawal symptoms associated with stopping Clozaril?

A: Official documents warn that if treatment is interrupted for mathbf2 mathbfdays mathbfor mathbfmore, it must be re-initiated slowly at a low dose to manage the risk of serious cardiovascular problems. Re-emerging or rebound psychotic symptoms have also been reported following discontinuation.


Q: Does Clozaril affect memory or concentration?

A: Yes, it can. The drug is associated with certain effects on the nervous system, and official labeling lists adverse reactions such as drowsiness, confusion, and the potential for cognitive impairment which can impact focus and memory.


Q: Can Clozaril cause heart rhythm changes?

A: Clozaril has been associated with QT Interval Prolongation, a potentially serious change in the heart's electrical system that can cause abnormal heart rhythms. The product label also notes that tachycardia (fast heart rate) is a very common side effect.


Q: Can Clozaril interact with birth control pills?

A: Yes. Official drug interaction information lists oral contraceptives as a type of medication that can increase the blood levels of Clozaril. This may increase the risk of experiencing side effects.


Q: What should I do if I am pregnant while taking Clozaril?

A: Use of Clozaril during pregnancy is not generally recommended unless the prescribing physician determines the benefit clearly outweighs the potential risks. Official warnings also state that breastfeeding is generally not recommended during therapy because the medicine is excreted into human milk.


Q: Can Clozaril cause high blood sugar?

A: Yes. Atypical antipsychotics, including Clozaril, have been linked to hyperglycemia (high blood sugar) and diabetes mellitus. These changes can be severe, and blood glucose levels should be monitored regularly during treatment.


Q: What happens if I stop smoking while on Clozaril?

A: Regulatory documents state that if a patient quits smoking, the concentration of Clozaril in the blood can increase significantly. This change may necessitate a review and potential adjustment of the Clozaril dosage by a healthcare provider.


Q: Can Clozaril cause excessive sweating?

A: Yes, official safety reports have documented a connection to sweating/sweating disturbance as an adverse effect. This has been reported in post-marketing surveillance.


Q: Can Clozaril cause blurry vision?

A: Yes. Blurred vision is listed in the official documentation as a common adverse reaction that can occur with the use of Clozaril.


Q: How does Clozaril affect the ability to concentrate?

A: Adverse reactions such as drowsiness, sedation, and confusion are common, which means they can potentially impact a person's ability to focus or concentrate.


Q: Can Clozaril cause sexual side effects?

A: Official postmarketing safety reports have included genitourinary adverse reactions such as changes in ejaculation and impotence.


Q: Is there a difference in side effects between the tablet and the oral suspension?

A: The official product documentation provides the same comprehensive warnings for serious adverse reactions, such as severe neutropenia and orthostatic hypotension, across the different oral formulations.


Q: Why is Clozaril not approved for the treatment of dementia-related psychosis?

A: Official warnings state that Clozaril is not approved for treating this condition because elderly patients with dementia-related psychosis who are treated with atypical antipsychotic drugs are at an increased risk of death.


Q: Why is Clozaril sometimes called clozapine?

A: Clozapine is the official active ingredient and the generic name of the medicine. Clozaril is one of the trade names (or brand names) under which the medicine is sold.


Q: What are the storage requirements for Clozaril tablets?

A: Clozaril tablets must be stored at controlled room temperature (between 20 C and 25 C). It is important that the product is protected from moisture and direct light.

How should Clozaril be stored and disposed of?

Storage and Handling

Clozaril tablets must be stored at a controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from moisture and direct light and should not be allowed to freeze. All formulations must be stored in a tight container and kept out of the reach of children, as required by regulatory labeling.

For the liquid oral suspension, the product must be discarded 100 days after the initial opening of the bottle. The suspension should not be refrigerated or frozen.

Disposal Requirements

Unused or expired Clozaril should be disposed of by following federal and local regulatory guidelines, utilizing drug take-back programs if available. If no take-back option is readily accessible, the FDA recommends discarding the tablets in the household trash. This requires mixing the uncrushed medicine with an unappealing substance (like used coffee grounds or dirt) and sealing the mixture in a container, then discarding it in the trash. Personal information on the packaging must be scratched out prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clozaril found in:

A-Z Index: